Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial.

K, Cusi; B, Orsak; F, Bril; R, Lomonaco; J, Hecht; C, Ortiz-Lopez; F, Tio; J, Hardies; C, Darland; N, Musi; A, Webb; P, Portillo-Sanchez

doi:10.7326/m15-1774

Public

Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial.

Shared by NobleBlocks on Jun 21, 2016 • 12:00 AM UTC

Authors:

Cusi K

Orsak B

Bril F

Abstract

Background The metabolic defects of nonalcoholic steatohepatitis (NASH) and prediabetes or type 2 diabetes mellitus (T2DM) seem to be specifically targeted by pioglitazone. However, information about its long-term use in this population is limited.Objective To determine the efficacy and safety of lo...

Discussions